Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02021682 · ClinicalTrials.gov registry record
CNS and Plasma Amyloid-Beta Kinetics in Alzheimer's Disease
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 58
- Enrollment target
NCT02021682: Completed study, sponsored by Washington University School of Medicine.
NCT02021682 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 58 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02021682 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 58 participants
- Enrollment target
Study Summary
Alzheimer's disease (AD) is the most common cause of dementia and currently has no disease modifying treatments or simple accurate diagnostic tests. The goal of this project is to study how amyloid-beta (a protein thought to cause AD) is made, transported and cleared in the human body. Better understanding of these processes may lead to improved understanding of AD, earlier diagnosis and a way to evaluate treatment.
Primary Outcome
Analysis of SILK blood and CSF Aβ isoforms will be performed. The pulse labeling blood Aβ SILK results of the amyloid positive group will be compared with the control group for Aβ38, Aβ40, Aβ42, and ratios of isoforms vs. tests of amyloidosis such as PET/PIB scan and/or CSF Aβ42 concentration.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2013-12 |
| Est. Completion | 2017-07 |
What the finished NCT02021682 record still lists
NCT02021682 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 58 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02021682 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02021682 about?
NCT02021682 is a clinical study titled "CNS and Plasma Amyloid-Beta Kinetics in Alzheimer's Disease". Alzheimer's disease (AD) is the most common cause of dementia and currently has no disease modifying treatments or simple accurate diagnostic tests. The goal of this project is to study how amyloid-beta (a protein thought to cause AD) is made, transported and cleared in the human body. Better unders...
What is the current status of trial NCT02021682?
This trial is currently completed. The enrollment target is 58 participants. The study started on 2013-12. Estimated completion is 2017-07.
Who is sponsoring clinical trial NCT02021682?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03587844 · 58 participants · Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- NCT03630991 · 58 participants · Phase 1
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- NCT03949855 · 58 participants · Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
- NCT04069273 · 58 participants · Phase 2
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia